{"id":22078,"date":"2024-03-26T01:13:37","date_gmt":"2024-03-26T01:13:37","guid":{"rendered":"https:\/\/cubegroup.com.au\/?post_type=studies&p=22078"},"modified":"2024-04-17T22:54:14","modified_gmt":"2024-04-17T22:54:14","slug":"unlocking-the-future-of-mental-health-treatment","status":"publish","type":"studies","link":"https:\/\/cubegroup.com.au\/studies\/unlocking-the-future-of-mental-health-treatment\/","title":{"rendered":"Unlocking the future of mental health treatment"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t
\n\t\t\t\t

Neuromedicines Innovation Australia (NIA, the Initiative) is a collaborative effort consisting of The Florey Institute of Neuroscience and Mental Health (the leading brain research centre in the southern hemisphere), and Australia\u2019s two highest ranking universities, Monash University and The University of Melbourne (The Times Higher Education<\/em> World University Rankings 2024<\/a><\/span>). These institutions are uniquely\u00a0placed to offer the end-to-end capability needed to develop different treatment options for mental health conditions.<\/p>

As of December 2023, mental and behavioural conditions were reported to impact over 1 in 4 Australians[1]<\/a>. Current mental health treatments fail to help one-third of people<\/strong> with these conditions[2]<\/a>, resulting in far-reaching implications, including for individuals living with the condition\/s, their families, carers, our society, and the economy. Examples of these implications include side effects from medications, including additional health issues (e.g., diabetes), reduced productivity and incarcerations.<\/p>

To address the increasing incidence of mental health conditions (and their corresponding implications) in Australia, NIA focuses on neuromedicines which include consciousness-alerting medicines (e.g., psilocybin, ketamine and MDMA[3]<\/sup><\/a>), as well as next generation, precision neuromedicines. These neuromedicines show promising signs of working faster, with enhanced efficacy and improved tolerability for mental health conditions compared to existing medicines. Neuromedicines may enhance psychotherapy and target multiple mental health conditions.<\/p>

The NIA exists to:<\/p>